Thomas Jefferson University - Steven K. Herrine
|
|
Steven K. Herrine
Medicine
Professor of Medicine
Division of Gastroenterology and Hepatology
Associate Medical Director of Liver Transplantation, Thomas Jefferson University Hospital
Assistant Dean for Academic Affairs, Jefferson Medical College
Appointed: 1995
|
|
|
|
|
Mailing Address
|
132 South 10th Street
Philadelphia, Pennsylvania 19107
United States
|
|
 |
|
|
Qualifications
|
B.A., Oberlin College, Highest Honors in Mathematics and History, 1982
M.D., Jefferson Medical College, magna cum laude, 1990
Board Certification, American Board of Internal Medicine, 1993, Recertification 2003
Board Certification, Gastroenterology, 1995, Recertification 2005
Board Certification, Transplant Hepatology, 2006
Medical Licensure, Commonwealth of Pennsylvania, 1992
|
|
|
Other Expertise
|
2004 Physician of the Year, American Liver Foundation, Delaware Valley Chapter
2004-2009 Best Doctors in America
2004, 2007, 2009 Thomas Jefferson University Internal Medicine Residency Teaching Award
2005, 2006 Excellence in Teaching Award, Jefferson Medical College
2005 Dean's Citation for Significant Contributions to the Advancement of Education at Jefferson Medical College
2006 Fellow, American Gastroenterological Association
2009 Dean's Awward for Distinguished Teaching, Jefferson Medical College
|
|
|
Keywords
|
|
Hepatitis; Hepatology; Liver Disorders; Liver Functions; Organ Transplantation
|
|
|
Publications
|
- Recent publications
- Herrine SK, Navarro VJ. Antiviral therapy of HCV in the cirrhotic and transplant candidate. Int J Med Sci 2006;3:73-76.
- Herrine SK, Rossi S, Navarro VJ. Management of the patient with chronic hepatitis C. Clin Exp Med 2006;6:20-26.
- Navarro VJ, Herrine S, Katopes C, Colombe B, Spain CV. The effect of HLA class I (A and B) and class II (DR) compatibility on liver transplantation outcomes: An analysis of the OPTN database. Liver Transpl 2006;12:652-658.
- Verma S, Mitchell DG, O'Kane P, Bergin D, Herrine SK. MRI diagnosis of multifocal hepatic inflammatory pseudotumor with primary sclerosing cholangitis: A differential entity. Eur J Radiol 2006;59:23-26.
- Mitchell DG, Navarro VJ, Herrine SK, Bergin D, Parker L, Frangos A, McCue P, Rubin R. Conpensated hepatitis C: unenhanced MR imaging correlated with pathologic staging and staging. Abdom Imaging. 2008;33:58-64
- Choi D, Mitchell DG, Verma SK, Bergin D, Navarro VJ, Malliah AB, McGowan C, Hann HL, Herrine SK. Hepatocellular carcinoma with indeterminate or false-negative initial imaging: effect on eligibility for curative treatment-initial observations. Radiology 2007;244:776-83
- Trooskin SB, Navarro VJ, Winn RJ, Axelrod DJ, McNeal AS, Velez M, Herrine SK, Rossi S. Hepatitis C risk assessment, testing and referral for treatment in urban primary care: role of race and ethnicity. World J Gastroenterol 2007;13:1074-78.
- Trooskin SB, Velez M, Rossi S, Herrine SK, Winn R, Axelrod DJ, McNeal AS, Navarro VJ. Racial and ethnic disparities in knowledge about hepatitis C. Open General and Internal Medicine Journal 2007;1:1-5.
- Jakab SS, Navarro VJ, Colombe BW, Daskalakis C, Herrine SK, Rossi S. Human leukocyte antigen and adult living-donor liver transplantation outcomes: an analysis of the organ procurement and transplantation network database. Liver Transpl 2007;13:1405-13.
- Rossi S, Assis DN, Awsare M, Brunner M, Skole K, Rai J, Andrel J, Herrine SK, Reddy RK, Navarro VJ. Use of over-the-counter analgesics in patients with chronic liver disease. Drug Safety 2008;31:261-70.
- Rustgi VK, Davis GL, Herrine, SK, McCullough AJ, Friedman SL, Gores GJ. Future trends in hepatology: challenges and opportunities. Hepatology 2008;48:655-61.
- Dhillon R, Rossi S, Herrine SK. Pegylated interferon 2a and 2b in combination with ribavirin for the treatment of chronic hepatitis C in HIV infected patients. Ther Clin Risk Manag 2008;4:789-96.
- Hashemi N, Rossi S, Navarro VJ, Herrine SK. Safety of peginterferon in the treatment of chronic hepatitis C. Expert Opin Drug Saf 2008;7:771-81.
- Mehendiratta V, Mitroo P, Bombonati A, Navarro VJ, Rossi S, Rubin R, Herrine SK. Serologic markers do not predict histologic severity or response to treatment in patients with autoimmune hepatitis. Clin Gastroenterol Hepatol. 2009;7:98-103.
- Verma SK, Mitchell DG, Bergin D, Lakhman Y, Austin A, Verma M, Assis D, Herrine SK, Parker L. Dilated cisternae chyli: a sign of uncompensated cirrhosis at MR imaging. Abdom Imaging 2009;34:211-16.
- Hojat M, Vergare MJ, Maxwell K, Brainard G, Herrine SK, Isenberg GA, Veloski J, Gonnella JS. The Devil is in the Third Year: A Longitudinal Study of Erosion of Empathy in Medical School. Acad Med. 2009; 84:11821191.
- Trooskin SB, Vega M, Herrine SK, Scott McNeal A, Winn RJ, Axelrod DJ, Navarro VJ. Prevalence of HCV Risk Factors in Hispanic-American Sub Populations. J Immigr Minor Health. 2009 Sep 1. [Epub ahead of print]
|
|
Individual Expertise profile of
Steven K. Herrine, Copyright © Steven K. Herrine.
Last Updated
by Steven Herrine : Thursday, September 24, 2009 11:08:04 AM
|
|
|---|
|
|
|
|
